The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)

Filter results
Date Title PDF
27/07/2020 First half 2020 results press release
9/07/2020 Moderna and ROVI Announce Collaboration for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
13/05/2020 First quarter 2020 results press release
14/04/2020 ROVI signs a co-operation agreement for a clinical trial to study the efficacy and safety of bemiparin in patients hospitalised with pneumonia caused by COVID-19
2/04/2020 ROVI informs on the impact of Covid 19 on the company’s activities
26/02/2020 Full year 2019 results press release
31/01/2020 ROVI announces the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union